SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Enze Jiang, Anna Junjie Shangguan, Shuangshuang Chen, Lin Tang, Shuang Zhao, Zhenghong Yu, The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma, Cancer Letters, 2015,

    CrossRef

  2. 2
    Jie Chen, Ling Yan, Feng-Cai Zhu, Jian-Xun Liu, Rong-Cheng Li, Fu-Zhen Wang, Jie Li, Hui Zhuang, Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother-to-infant transmission, Journal of Medical Virology, 2014, 86, 8
  3. 3
    Xiaoguo Zhang, Lu Liu, Wansu Xu, Yun Wang, Shuchun Gao, Shijun Chen, Yizhen Du, Intracellular levels of hepatitis�B virus DNA and mutational patterns of the polymerase gene of hepatitis�B virus in peripheral blood mononuclear cells of patients with lamivudine or telbivudine resistance, Experimental and Therapeutic Medicine, 2014,

    CrossRef

  4. 4
    En-Qiang Chen, Ying Shi, Dong-Bo Wu, Hong Tang, Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection, Expert Review of Anti-infective Therapy, 2014, 12, 8, 919

    CrossRef

  5. 5
    Chloe L. Thio, Laura Smeaton, Melissa Saulynas, Hyon Hwang, Shanmugam Saravan, Smita Kulkarni, James Hakim, Mulinda Nyirenda, Hussain S. Iqbal, Umesh G. Lalloo, Anand S. Mehta, Kimberly Hollabaugh, Thomas B. Campbell, Shahin Lockman, Judith S. Currier, Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort, AIDS, 2013, 27, 2, 191

    CrossRef

  6. 6
    Jun Lei, Ying Wang, Li-Li Wang, Shao-Jun Zhang, Wei Chen, Zhi-Gang Bai, Lv-Ye Xu, Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B, Virology Journal, 2013, 10, 1, 313

    CrossRef

  7. 7
    Judith M. Fontana, Elizabeth Alexander, Mirella Salvatore, Translational research in infectious disease: current paradigms and challenges ahead, Translational Research, 2012, 159, 6, 430

    CrossRef